MANUFACTURERS LIFE INSURANCE COMPANY, THE - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,064,241
-86.6%
54,265
-68.0%
0.00%
-88.9%
Q2 2023$15,457,210
+71.6%
169,673
+24.2%
0.01%
+80.0%
Q1 2023$9,009,872
+110.8%
136,596
+64.9%
0.01%
+66.7%
Q4 2022$4,274,664
-31.0%
82,830
-11.0%
0.00%
-25.0%
Q3 2022$6,193,182
+41.4%
93,084
-3.9%
0.00%
+33.3%
Q2 2022$4,378,932
-12.5%
96,876
-3.4%
0.00%0.0%
Q1 2022$5,002,037
+191.7%
100,299
+179.0%
0.00%
+200.0%
Q4 2021$1,715,000
+53.0%
35,949
+5.7%
0.00%0.0%
Q3 2021$1,121,000
-51.7%
34,024
-7.4%
0.00%
-50.0%
Q2 2021$2,323,000
+58.2%
36,757
+7.4%
0.00%
+100.0%
Q1 2021$1,468,000
-29.3%
34,216
-5.7%
0.00%
-50.0%
Q4 2020$2,075,000
+94.7%
36,278
+2.7%
0.00%
+100.0%
Q3 2020$1,066,000
-3.7%
35,338
-1.8%
0.00%0.0%
Q2 2020$1,107,000
+15.6%
35,973
+0.6%
0.00%0.0%
Q1 2020$958,000
+5.9%
35,742
+21.0%
0.00%0.0%
Q4 2019$905,000
+20.8%
29,551
-3.7%
0.00%0.0%
Q3 2019$749,000
-2.9%
30,677
+0.8%
0.00%0.0%
Q2 2019$771,000
+61.3%
30,429
+24.1%
0.00%0.0%
Q1 2019$478,000
+59.9%
24,511
+7.9%
0.00%
Q4 2018$299,000
-31.4%
22,714
-7.4%
0.00%
Q3 2018$436,000
-28.1%
24,536
-10.8%
0.00%
-100.0%
Q2 2018$606,000
+184.5%
27,514
+186.5%
0.00%
Q1 2018$213,000
+14.5%
9,602
+12.3%
0.00%
Q4 2017$186,0008,5510.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders